<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00388661</url>
  </required_header>
  <id_info>
    <org_study_id>R-06.31 M / Melody</org_study_id>
    <secondary_id>R-06.31 M</secondary_id>
    <nct_id>NCT00388661</nct_id>
  </id_info>
  <brief_title>Melatonin and Quality of Life in Dialysis Patients</brief_title>
  <official_title>Double Blind Placebo-controlled Study on the Efficacy of Melatonin on Sleep, Resulting in an Improved Quality of Life in Hemodialysis Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Meander Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Dutch Kidney Foundation</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Meander Medical Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Sleep problems can lead to a bad quality of life and a raise of morbidity, also in dialysis&#xD;
      patients. Sleep problems can be caused by a disturbance of circadian rhythms in our body. For&#xD;
      a good regulation of these circadian rhythms a uniform external synchronisation is necessary.&#xD;
      This is the synchronisation of the biological clock of our body by light and other&#xD;
      influences. In case of a disturbance of the external synchronisation, due to for example naps&#xD;
      during the day or wake periods at night, internal rhythms can be unlinked. As a result a&#xD;
      weakened melatonin rhythm and a problematic sleep-wake cycle can be observed. Most dialysis&#xD;
      patients have sleep problems. Their sleep latency is prolonged. They often take a nap during&#xD;
      the day and their sleep efficiency is poor. There has only been one study on the melatonin&#xD;
      rhythm of dialysis patients. The conclusion of this study was that the melatonin rhythm of&#xD;
      dialysis patients is weakened and disturbed, probably caused by renal insufficiency. In this&#xD;
      study no link was made between melatonin rhythm and the nature and severity of possible sleep&#xD;
      problems. In different studies with non-dialysis patients and a disturbed melatonin rhythm,&#xD;
      exogenous melatonin at the right time leads to a recovery of the normal rhythm and the normal&#xD;
      biological clock and a better quality of life.&#xD;
&#xD;
      The aim is to improve quality of life of hemodialysis patients with a placebo-controlled&#xD;
      study with melatonin to investigate if exogenous melatonin can improve sleep problems and on&#xD;
      the longer term improve quality of life (and secondary morbidity) of dialysis patients.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Objective of the study:&#xD;
&#xD;
      Does melatonin by improving sleep parameters improve quality of life of hemodialysis&#xD;
      patients?&#xD;
&#xD;
      Study design:&#xD;
&#xD;
      Placebo-controlled, double-blind, randomized trial&#xD;
&#xD;
      Study population:&#xD;
&#xD;
      hemodialysis patients&#xD;
&#xD;
      Intervention:&#xD;
&#xD;
      melatonin 3 mg once daily (or placebo)&#xD;
&#xD;
      Primary study parameters/outcome of the study:&#xD;
&#xD;
        1. improvement of vitality (dimension quality of life) by 15 points (RAND SF 36)&#xD;
&#xD;
        2. improvement general health by 15 points (dimension quality of life, RAND SF 36)&#xD;
&#xD;
      Secondary study parameters/outcome of the study:&#xD;
&#xD;
        1. Change in biochemical parameters&#xD;
&#xD;
        2. Change in ProBNP&#xD;
&#xD;
        3. Change in nutritional status&#xD;
&#xD;
        4. Change in use of medication&#xD;
&#xD;
        5. Change in preload&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>April 2007</start_date>
  <completion_date type="Actual">December 2009</completion_date>
  <primary_completion_date type="Actual">October 2009</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Improvement of vitality (dimension quality of life) by 15 points (RAND SF 36)</measure>
    <time_frame>6-12 months</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Improvement general health by 15 points (dimension quality of life, RAND SF 36)</measure>
    <time_frame>6-12 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in biochemical parameters</measure>
    <time_frame>3-6-9-12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in ProBNP</measure>
    <time_frame>12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in nutritional status</measure>
    <time_frame>12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in use of medication</measure>
    <time_frame>6-12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in preload</measure>
    <time_frame>12 months</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">68</enrollment>
  <condition>Sleep Problems</condition>
  <condition>Haemodialysis</condition>
  <arm_group>
    <arm_group_label>Melatonin</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>melatonin 3mg</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Melatonin tablet 3 mg once daily</intervention_name>
    <description>Melatonin tablet 3 mg once daily</description>
    <arm_group_label>Melatonin</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo comparator</intervention_name>
    <description>Placebo comparator</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Informed Consent&#xD;
&#xD;
          -  Man/Women between 18 and 85 years&#xD;
&#xD;
          -  Understanding and knowledge of the dutch language&#xD;
&#xD;
          -  End Stage Renal Disease, stable chronic hemodialysis &gt; 3 months&#xD;
&#xD;
          -  SpKt/V(total) &gt; 1,2 pro dialysis&#xD;
&#xD;
          -  Validated actometer shows that sleep efficiency &lt; 90% or sleep latency &gt; 15 minutes or&#xD;
             fragmentation index &gt; 25 points&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Known major illness, which interferes with patient's participation in the study&#xD;
             according to the investigator)or which results in a probable patient's survival of&#xD;
             less than 1 year.&#xD;
&#xD;
          -  Instable angina pectoris, heart failure NYHA class IV&#xD;
&#xD;
          -  Pregnancy&#xD;
&#xD;
          -  Current use of melatonin of known allergy of melatonin&#xD;
&#xD;
          -  Participation in other medication/drug research within a month before inclusion&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Pieter ter Wee, MD, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>VU University Medical Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Meander Medical Center</name>
      <address>
        <city>Amersfoort</city>
        <zip>3800 BM</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kennemer Gasthuis</name>
      <address>
        <city>Haarlem</city>
        <zip>2035 RC</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Netherlands</country>
  </location_countries>
  <verification_date>July 2011</verification_date>
  <study_first_submitted>October 16, 2006</study_first_submitted>
  <study_first_submitted_qc>October 16, 2006</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 17, 2006</study_first_posted>
  <last_update_submitted>July 19, 2011</last_update_submitted>
  <last_update_submitted_qc>July 19, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 20, 2011</last_update_posted>
  <responsible_party>
    <name_title>Department of Clinical Pharmacy</name_title>
    <organization>Meander Medical Center</organization>
  </responsible_party>
  <keyword>sleep problems</keyword>
  <keyword>quality of life</keyword>
  <keyword>melatonin</keyword>
  <keyword>sleep apnea</keyword>
  <keyword>medication</keyword>
  <keyword>preload</keyword>
  <keyword>nutritional status</keyword>
  <keyword>ProBNP</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dyssomnias</mesh_term>
    <mesh_term>Parasomnias</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Melatonin</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

